Revolution Medicines, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -31.0% | -31.0% | -25.4% |
| FY2022 | -36.3% | -36.3% | -30.6% |
| FY2023 | -23.9% | -23.9% | -21.2% |
| FY2024 | -26.5% | -26.5% | -23.5% |
| FY2025 | -69.3% | -69.3% | -48.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -31.0% | -31.0% | -25.4% |
| FY2022 | -36.3% | -36.3% | -30.6% |
| FY2023 | -23.9% | -23.9% | -21.2% |
| FY2024 | -26.5% | -26.5% | -23.5% |
| FY2025 | -69.3% | -69.3% | -48.0% |